LANSOPRAZOLE
| Brand name | LANSOPRAZOLE |
|---|---|
| Active ingredient | LANSOPRAZOLE |
| Strength | 15MG |
| Dosage form | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | June 2016 |
| Marketing status | OTC |
| Patent | Expires | Type |
|---|---|---|
| 11077055 | April 2036 | product |
| 11986554 | April 2036 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.